Annual CFF
$3.50 B
+$8.90 B+164.65%
31 December 2023
Summary:
Eli Lilly and Company annual cash flow from financing activities is currently $3.50 billion, with the most recent change of +$8.90 billion (+164.65%) on 31 December 2023. During the last 3 years, it has risen by +$6.63 billion (+211.43%). LLY annual CFF is now at all-time high.LLY Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$211.30 M
-$1.34 B-86.42%
30 September 2024
Summary:
Eli Lilly and Company quarterly cash flow from financing activities is currently $211.30 million, with the most recent change of -$1.34 billion (-86.42%) on 30 September 2024. Over the past year, it has dropped by -$360.70 million (-63.06%). LLY quarterly CFF is now -95.08% below its all-time high of $4.30 billion, reached on 31 December 2008.LLY Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$5.00 B
-$360.70 M-6.73%
30 September 2024
Summary:
Eli Lilly and Company TTM cash flow from financing activities is currently $5.00 billion, with the most recent change of -$360.70 million (-6.73%) on 30 September 2024. Over the past year, it has increased by +$6.19 billion (+520.01%). LLY TTM CFF is now -6.73% below its all-time high of $5.36 billion, reached on 30 June 2024.LLY TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +164.7% | -63.1% | +520.0% |
| 3 y3 years | +211.4% | +145.6% | +228.3% |
| 5 y5 years | +159.2% | +112.5% | +275.4% |
LLY Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +164.7% | -94.0% | +107.3% | -6.7% | +184.0% |
| 5 y | 5 years | at high | +159.2% | -94.0% | +107.3% | -6.7% | +184.0% |
| alltime | all time | at high | +159.2% | -95.1% | +105.5% | -6.7% | +184.0% |
Eli Lilly And Company Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $211.30 M(-86.4%) | $5.00 B(-6.7%) |
| June 2024 | - | $1.56 B(-599.7%) | $5.36 B(+93.4%) |
| Mar 2024 | - | -$311.30 M(-108.8%) | $2.77 B(-20.7%) |
| Dec 2023 | $3.50 B(-164.7%) | $3.54 B(+519.7%) | $3.50 B(-393.6%) |
| Sept 2023 | - | $572.00 M(-155.4%) | -$1.19 B(-60.7%) |
| June 2023 | - | -$1.03 B(-350.6%) | -$3.03 B(+43.0%) |
| Mar 2023 | - | $412.30 M(-136.1%) | -$2.12 B(-60.9%) |
| Dec 2022 | -$5.41 B(+30.9%) | -$1.14 B(-9.6%) | -$5.41 B(-6.6%) |
| Sept 2022 | - | -$1.26 B(+921.3%) | -$5.79 B(+16.0%) |
| June 2022 | - | -$123.70 M(-95.7%) | -$4.99 B(-16.1%) |
| Mar 2022 | - | -$2.88 B(+88.6%) | -$5.95 B(+44.1%) |
| Dec 2021 | -$4.13 B(+31.7%) | -$1.53 B(+229.6%) | -$4.13 B(+6.0%) |
| Sept 2021 | - | -$463.20 M(-57.2%) | -$3.90 B(+5.0%) |
| June 2021 | - | -$1.08 B(+2.3%) | -$3.71 B(-13.7%) |
| Mar 2021 | - | -$1.06 B(-18.0%) | -$4.30 B(+37.1%) |
| Dec 2020 | -$3.14 B(+35.0%) | -$1.29 B(+362.7%) | -$3.14 B(+6.0%) |
| Sept 2020 | - | -$279.10 M(-83.3%) | -$2.96 B(-32.3%) |
| June 2020 | - | -$1.67 B(-1668.1%) | -$4.37 B(+22.0%) |
| Mar 2020 | - | $106.70 M(-109.6%) | -$3.59 B(+54.3%) |
| Dec 2019 | -$2.32 B(-60.6%) | -$1.11 B(-34.2%) | -$2.32 B(-18.5%) |
| Sept 2019 | - | -$1.69 B(+91.1%) | -$2.85 B(+293.2%) |
| June 2019 | - | -$885.80 M(-164.8%) | -$725.00 M(+8.1%) |
| Mar 2019 | - | $1.37 B(-183.4%) | -$670.60 M(-88.6%) |
| Dec 2018 | -$5.90 B(-4240.9%) | -$1.64 B(-478.9%) | -$5.90 B(+22.8%) |
| Sept 2018 | - | $432.70 M(-152.0%) | -$4.81 B(+1.4%) |
| June 2018 | - | -$831.40 M(-78.5%) | -$4.74 B(+66.4%) |
| Mar 2018 | - | -$3.87 B(+613.0%) | -$2.85 B(-2097.3%) |
| Dec 2017 | $142.60 M(-125.5%) | -$542.30 M(-208.3%) | $142.60 M(-86.7%) |
| Sept 2017 | - | $500.70 M(-52.8%) | $1.07 B(-3585.7%) |
| June 2017 | - | $1.06 B(-221.0%) | -$30.70 M(-94.0%) |
| Mar 2017 | - | -$875.70 M(-327.3%) | -$511.30 M(-8.7%) |
| Dec 2016 | -$559.80 M(-82.0%) | $385.20 M(-164.2%) | -$559.80 M(-69.2%) |
| Sept 2016 | - | -$600.10 M(-203.6%) | -$1.82 B(+0.3%) |
| June 2016 | - | $579.30 M(-162.7%) | -$1.81 B(-45.7%) |
| Mar 2016 | - | -$924.20 M(+6.1%) | -$3.33 B(+7.2%) |
| Dec 2015 | -$3.11 B(+1769.6%) | -$871.40 M(+46.4%) | -$3.11 B(+342.8%) |
| Sept 2015 | - | -$595.20 M(-36.9%) | -$702.50 M(+36.9%) |
| June 2015 | - | -$943.20 M(+34.5%) | -$513.20 M(+88.3%) |
| Mar 2015 | - | -$701.20 M(-145.6%) | -$272.50 M(+63.8%) |
| Dec 2014 | -$166.40 M(-95.7%) | $1.54 B(-478.7%) | -$166.40 M(-93.9%) |
| Sept 2014 | - | -$405.90 M(-42.2%) | -$2.74 B(-4.3%) |
| June 2014 | - | -$702.50 M(+18.0%) | -$2.86 B(+6.3%) |
| Mar 2014 | - | -$595.10 M(-42.6%) | -$2.69 B(-29.6%) |
| Dec 2013 | -$3.83 B(-13.4%) | -$1.04 B(+95.9%) | -$3.83 B(-5.6%) |
| Sept 2013 | - | -$529.00 M(-0.9%) | -$4.06 B(-0.4%) |
| June 2013 | - | -$533.80 M(-69.1%) | -$4.07 B(-0.5%) |
| Mar 2013 | - | -$1.73 B(+36.7%) | -$4.09 B(-7.4%) |
| Dec 2012 | -$4.42 B(+86.5%) | -$1.27 B(+132.3%) | -$4.42 B(+16.1%) |
| Sept 2012 | - | -$544.70 M(-1.4%) | -$3.81 B(+2.8%) |
| June 2012 | - | -$552.70 M(-73.1%) | -$3.70 B(-0.3%) |
| Mar 2012 | - | -$2.06 B(+216.0%) | -$3.71 B(+56.7%) |
| Dec 2011 | -$2.37 B(+17.2%) | -$650.90 M(+47.6%) | -$2.37 B(+4.5%) |
| Sept 2011 | - | -$440.90 M(-21.9%) | -$2.27 B(+2.1%) |
| June 2011 | - | -$564.30 M(-20.9%) | -$2.22 B(+1.5%) |
| Mar 2011 | - | -$713.80 M(+29.9%) | -$2.19 B(+8.2%) |
| Dec 2010 | -$2.02 B(-63.5%) | -$549.60 M(+39.6%) | -$2.02 B(-22.3%) |
| Sept 2010 | - | -$393.80 M(-25.9%) | -$2.60 B(-16.6%) |
| June 2010 | - | -$531.50 M(-2.8%) | -$3.12 B(-15.7%) |
| Mar 2010 | - | -$547.00 M(-51.5%) | -$3.70 B(-33.1%) |
| Dec 2009 | -$5.53 B(-335.9%) | -$1.13 B(+23.6%) | -$5.53 B(+5023.8%) |
| Sept 2009 | - | -$913.20 M(-17.8%) | -$108.00 M(-145.1%) |
| June 2009 | - | -$1.11 B(-53.3%) | $239.40 M(-71.1%) |
| Mar 2009 | - | -$2.38 B(-155.4%) | $827.50 M(-64.7%) |
| Dec 2008 | $2.35 B(-377.7%) | $4.30 B(-859.5%) | $2.35 B(-196.1%) |
| Sept 2008 | - | -$565.80 M(+8.1%) | -$2.44 B(-0.3%) |
| June 2008 | - | -$523.50 M(-39.3%) | -$2.45 B(-7.6%) |
| Mar 2008 | - | -$861.90 M(+75.6%) | -$2.65 B(+213.7%) |
| Dec 2007 | -$844.90 M | -$490.70 M(-14.4%) | -$844.90 M(-56.9%) |
| Sept 2007 | - | -$573.20 M(-20.9%) | -$1.96 B(-40.5%) |
| June 2007 | - | -$724.60 M(-176.8%) | -$3.29 B(+9.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $943.60 M(-158.8%) | -$2.99 B(-34.6%) |
| Dec 2006 | -$4.58 B(+143.5%) | -$1.60 B(-15.8%) | -$4.58 B(+22.9%) |
| Sept 2006 | - | -$1.91 B(+345.9%) | -$3.73 B(+1212.1%) |
| June 2006 | - | -$427.50 M(-33.2%) | -$284.00 M(+20.5%) |
| Mar 2006 | - | -$640.30 M(-14.9%) | -$235.70 M(-87.5%) |
| Dec 2005 | -$1.88 B(-1023.2%) | -$752.60 M(-149.0%) | -$1.88 B(+63.5%) |
| Sept 2005 | - | $1.54 B(-505.2%) | -$1.15 B(-44.9%) |
| June 2005 | - | -$379.20 M(-83.4%) | -$2.09 B(-0.6%) |
| Mar 2005 | - | -$2.29 B(>+9900.0%) | -$2.10 B(-1130.9%) |
| Dec 2004 | $203.70 M(-112.9%) | -$22.30 M(-103.7%) | $203.70 M(-153.0%) |
| Sept 2004 | - | $600.00 M(-252.9%) | -$384.00 M(-63.5%) |
| June 2004 | - | -$392.50 M(-2221.6%) | -$1.05 B(-13.4%) |
| Mar 2004 | - | $18.50 M(-103.0%) | -$1.22 B(-22.9%) |
| Dec 2003 | -$1.58 B(+274.0%) | -$610.00 M(+781.5%) | -$1.58 B(-11.8%) |
| Sept 2003 | - | -$69.20 M(-87.6%) | -$1.79 B(+75.8%) |
| June 2003 | - | -$556.00 M(+62.1%) | -$1.02 B(+14.6%) |
| Mar 2003 | - | -$343.10 M(-58.2%) | -$888.60 M(+110.6%) |
| Dec 2002 | -$422.00 M(-59.8%) | -$820.70 M(-216.9%) | -$422.00 M(+300.0%) |
| Sept 2002 | - | $701.90 M(-264.5%) | -$105.50 M(-89.3%) |
| June 2002 | - | -$426.70 M(-445.5%) | -$986.60 M(+55.7%) |
| Mar 2002 | - | $123.50 M(-124.5%) | -$633.80 M(-39.6%) |
| Dec 2001 | -$1.05 B(-53.0%) | -$504.20 M(+181.4%) | -$1.05 B(-3.3%) |
| Sept 2001 | - | -$179.20 M(+142.5%) | -$1.08 B(-25.2%) |
| June 2001 | - | -$73.90 M(-74.6%) | -$1.45 B(-21.6%) |
| Mar 2001 | - | -$291.40 M(-46.0%) | -$1.85 B(-17.1%) |
| Dec 2000 | -$2.23 B(+53.5%) | -$539.50 M(-0.8%) | -$2.23 B(+9.9%) |
| Sept 2000 | - | -$543.90 M(+15.1%) | -$2.03 B(+71.1%) |
| June 2000 | - | -$472.40 M(-29.9%) | -$1.19 B(-26.1%) |
| Mar 2000 | - | -$673.70 M(+99.3%) | -$1.60 B(+10.4%) |
| Dec 1999 | -$1.45 B(-48.4%) | -$338.00 M(-213.2%) | -$1.45 B(-31.3%) |
| Sept 1999 | - | $298.60 M(-133.5%) | -$2.11 B(-26.7%) |
| June 1999 | - | -$890.70 M(+70.4%) | -$2.88 B(+8.6%) |
| Mar 1999 | - | -$522.60 M(-47.7%) | -$2.66 B(-5.6%) |
| Dec 1998 | -$2.81 B(+43.9%) | -$999.20 M(+112.0%) | -$2.81 B(+37.1%) |
| Sept 1998 | - | -$471.40 M(-28.9%) | -$2.05 B(-13.1%) |
| June 1998 | - | -$662.60 M(-2.5%) | -$2.36 B(-9.6%) |
| Mar 1998 | - | -$679.50 M(+186.2%) | -$2.61 B(+33.6%) |
| Dec 1997 | -$1.95 B(+17.7%) | -$237.40 M(-69.6%) | -$1.95 B(-11.7%) |
| Sept 1997 | - | -$781.30 M(-14.5%) | -$2.21 B(+1.9%) |
| June 1997 | - | -$913.50 M(+3978.1%) | -$2.17 B(+36.0%) |
| Mar 1997 | - | -$22.40 M(-95.5%) | -$1.60 B(-3.8%) |
| Dec 1996 | -$1.66 B(+104.1%) | -$496.50 M(-32.9%) | -$1.66 B(+1.5%) |
| Sept 1996 | - | -$739.50 M(+118.2%) | -$1.64 B(+38.6%) |
| June 1996 | - | -$338.90 M(+293.2%) | -$1.18 B(+8.6%) |
| Mar 1996 | - | -$86.20 M(-81.7%) | -$1.09 B(+33.7%) |
| Dec 1995 | -$813.70 M(-128.7%) | -$472.30 M(+66.5%) | -$813.70 M(-132.4%) |
| Sept 1995 | - | -$283.60 M(+15.4%) | $2.51 B(-5.9%) |
| June 1995 | - | -$245.80 M(-230.7%) | $2.67 B(-9.3%) |
| Mar 1995 | - | $188.00 M(-93.4%) | $2.94 B(+3.8%) |
| Dec 1994 | $2.84 B(-642.4%) | $2.86 B(-2348.6%) | $2.84 B(-1297.2%) |
| Sept 1994 | - | -$127.00 M(-563.5%) | -$237.00 M(-38.0%) |
| June 1994 | - | $27.40 M(-66.3%) | -$382.20 M(-41.6%) |
| Mar 1994 | - | $81.20 M(-137.1%) | -$654.10 M(+25.0%) |
| Dec 1993 | -$523.10 M(-11.1%) | -$218.60 M(-19.7%) | -$523.10 M(-33.6%) |
| Sept 1993 | - | -$272.20 M(+11.3%) | -$788.20 M(+55.9%) |
| June 1993 | - | -$244.50 M(-215.2%) | -$505.70 M(+55.4%) |
| Mar 1993 | - | $212.20 M(-143.9%) | -$325.40 M(-44.7%) |
| Dec 1992 | -$588.60 M(+111.6%) | -$483.70 M(-4796.1%) | -$588.60 M(+97.8%) |
| Sept 1992 | - | $10.30 M(-116.0%) | -$297.60 M(-40.6%) |
| June 1992 | - | -$64.20 M(+25.9%) | -$500.90 M(+46.7%) |
| Mar 1992 | - | -$51.00 M(-73.5%) | -$341.40 M(+22.7%) |
| Dec 1991 | -$278.20 M(-29.3%) | -$192.70 M(-0.2%) | -$278.20 M(+25.1%) |
| Sept 1991 | - | -$193.00 M(-302.5%) | -$222.30 M(+40.3%) |
| June 1991 | - | $95.30 M(+681.1%) | -$158.50 M(-52.6%) |
| Mar 1991 | - | $12.20 M(-108.9%) | -$334.70 M(-15.0%) |
| Dec 1990 | -$393.70 M(-26.7%) | -$136.80 M(+5.9%) | -$393.70 M(+53.3%) |
| Sept 1990 | - | -$129.20 M(+59.7%) | -$256.90 M(+101.2%) |
| June 1990 | - | -$80.90 M(+72.9%) | -$127.70 M(+172.9%) |
| Mar 1990 | - | -$46.80 M | -$46.80 M |
| Dec 1989 | -$537.00 M | - | - |
FAQ
- What is Eli Lilly and Company annual cash flow from financing activities?
- What is the all time high annual CFF for Eli Lilly and Company?
- What is Eli Lilly and Company annual CFF year-on-year change?
- What is Eli Lilly and Company quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly CFF year-on-year change?
- What is Eli Lilly and Company TTM cash flow from financing activities?
- What is the all time high TTM CFF for Eli Lilly and Company?
- What is Eli Lilly and Company TTM CFF year-on-year change?
What is Eli Lilly and Company annual cash flow from financing activities?
The current annual CFF of LLY is $3.50 B
What is the all time high annual CFF for Eli Lilly and Company?
Eli Lilly and Company all-time high annual cash flow from financing activities is $3.50 B
What is Eli Lilly and Company annual CFF year-on-year change?
Over the past year, LLY annual cash flow from financing activities has changed by +$8.90 B (+164.65%)
What is Eli Lilly and Company quarterly cash flow from financing activities?
The current quarterly CFF of LLY is $211.30 M
What is the all time high quarterly CFF for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly cash flow from financing activities is $4.30 B
What is Eli Lilly and Company quarterly CFF year-on-year change?
Over the past year, LLY quarterly cash flow from financing activities has changed by -$360.70 M (-63.06%)
What is Eli Lilly and Company TTM cash flow from financing activities?
The current TTM CFF of LLY is $5.00 B
What is the all time high TTM CFF for Eli Lilly and Company?
Eli Lilly and Company all-time high TTM cash flow from financing activities is $5.36 B
What is Eli Lilly and Company TTM CFF year-on-year change?
Over the past year, LLY TTM cash flow from financing activities has changed by +$6.19 B (+520.01%)